Estimation of cumulative number of post-treatment Lyme disease cases in the US, 2016 and 2020.

The cumulative prevalence of PLTD in the United States is estimated to be high and continues to increase. These findings will be of interest to epidemiologists and health economists studying disease burden in the US and elsewhere, and justify funding to study PTLD diagnosis and treatment.